Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tenofovir Alafenamide Fumarate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableUnknownNCT03640728
What this trial is testing

The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

Who this might be right for
Hepatitis BVirus DiseasesLiver Failure
First Affiliated Hospital Xi'an Jiaotong University 200
Not applicableNot Yet RecruitingNCT07812571
What this trial is testing

Tenofovir Exposures in Advanced Kidney Disease Study

Who this might be right for
TenofovirTenofovir Alafenamide FumarateChronic Kidney Diease+2 more
King's College Hospital NHS Trust 50
Large-scale testing (Phase 3)Study completedNCT02616783
What this trial is testing

Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years

Who this might be right for
HIV-1 Infection
Gilead Sciences 167
Post-approval studies (Phase 4)Ended earlyNCT04665375
What this trial is testing

Can INSTI-associated Weight Gain be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF?

Who this might be right for
HivWeight Gain
University Health Network, Toronto 4
Testing effectiveness (Phase 2)Study completedNCT05458765
What this trial is testing

Project Engage: Oral PrEP Acceptability

Who this might be right for
Acceptability of Health CareAdherence, Medication
Eastern Virginia Medical School 330
Post-approval studies (Phase 4)Study completedNCT03717129
What this trial is testing

Analysis of Crushed and Whole Tablet Genvoya

Who this might be right for
Healthy Volunteers
Johns Hopkins University 12
Post-approval studies (Phase 4)Study completedNCT02771054
What this trial is testing

Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation

Who this might be right for
HIV
Göteborg University 22
Testing effectiveness (Phase 2)Study completedNCT03905655
What this trial is testing

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Romark Laboratories L.C. 51
Large-scale testing (Phase 3)Study completedNCT01940341
What this trial is testing

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Who this might be right for
HBeAg-negative Chronic Hepatitis B
Gilead Sciences 426
Post-approval studies (Phase 4)UnknownNCT05326971
What this trial is testing

The Effect Tenofovir Disoproxil Fumarate (TDF) and Tenofovir Alafenamide (TAF) on Small Intestine Gut Wall

Who this might be right for
HIV InfectionsWeight Gain
Jussi Sutinen 24
Large-scale testing (Phase 3)Study completedNCT03547908
What this trial is testing

Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

Who this might be right for
HIV-1/HBV Co-Infection
Gilead Sciences 244
Large-scale testing (Phase 3)Study completedNCT02431247
What this trial is testing

Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Who this might be right for
Immunodeficiency Virus Type 1, Human
Janssen Sciences Ireland UC 725
Large-scale testing (Phase 3)Study completedNCT02345226
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 881